QA: Abbott Laboratories in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2024_Abbott_Laboratories.pdf

Logs

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 22,670,000,000
1 IntangibleAssetsNetIncludingGoodwill 32,494,000,000
2 PropertyPlantAndEquipmentNet 10,154,000,000
3 remainder_Assets 7,896,000,000
4 LiabilitiesCurrent 13,841,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,865,101,753
8 SellingGeneralAndAdministrativeExpense 10,862,156,601
9 ResearchAndDevelopmentExpense 2,698,805,370
10 remainder_Expenses 3,586,186,512
11 remainder_Revenues 39,460,871,583
12 remainder_NetIncome 684,686,809
13 remainder_ComprehensiveNetIncome 242,726,860
  yvar yval
0 Assets 73,214,000,000
1 Liabilities 13,841,000,000
2 Expenses 35,012,250,236
3 Revenues 39,460,871,583
4 StockholdersEquity 59,373,000,000
5 NetIncome 5,133,308,156
6 ComprehensiveNetIncome 5,254,671,586
7 BaseVar 81,227,767,744
8 EconomicCapitalRatiobeforeLimitedLiability 3.09
9 EconomicCapitalRatio 3.75

Edgar->Model Mapping

Feature Distribution

Change over Time